Platelet biomarkers in cancer diagnosis
US10054596B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2014 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | Mar 24, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7028
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present embodiments relate generally to the field of cancer diagnostics. More specifically the embodiments relate to platelet derived biomarkers used for diagnosis of cancer or cancer progression, as well as prognosis and improved treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.